PDS Biotechnology Price Target Raised to $4.00/Share From $3.00 by B. Riley Securities
Ratings actions from Benzinga
Related stories
Eastman Chemical Reports Quarterly Results Through September 30
The LSEG-generated earnings summary covers Eastman Chemical Co.'s quarter ended September 30.
M impact | EQUITY | Oct 29, 2026, 11:58 PM UTC
Coles Shares Fall 12% After Sales Disappoint, Fuel Costs Threaten Profits
Coles said supermarket same-store sales rose 2.7% in the 13 weeks through Sept. 27 and warned that rising fuel costs would hurt profits. Its shares fell 12%, putting them on course
M impact | EQUITY | Oct 29, 2026, 11:57 PM UTC
TFS Financial Reports Quarterly Results
TFS Financial Corp reported results for the quarter ended September 30.
M impact | EQUITY | Oct 29, 2026, 11:56 PM UTC
FirstCash Shares Decline 14.75% as Law Firm Investigates Potential Securities Fraud
The Law Offices of Frank R. Cruz says it continues investigating potential securities fraud after a 14.75% decline in FirstCash Holdings shares.
M impact | EQUITY | Oct 29, 2026, 11:56 PM UTC
First Northern Reports Higher Third-Quarter Net Profit
First Northern said net profit rose in the third quarter of 2026 compared with the previous quarter.
M impact | EQUITY | Oct 29, 2026, 11:56 PM UTC
Innovotech Secures $600,000 in Credit Facilities From ATB Financial
Innovotech said it established a banking partnership with ATB Financial, securing $600,000 in credit facilities to support growth.
M impact | EQUITY | Oct 29, 2026, 11:55 PM UTC